Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC424

Teclistamab

  • Status:
    Veitt
  • Application date:
    22.2.2023
  • Application published:
    15.3.2023
  • Grant published:
    15.10.2024
  • Max expiry date:
    23.8.2037
  • Medicine name:
    Tecvayli
  • Medicine for children:
    No

Timeline

Today
22.2.2023Application
15.3.2023Publication
15.10.2024Registration
23.8.2037Expires

Marketing license

    • Foreign authorization number:
      EU/1/22/1675
    • Date:
      23.8.2022

    Owner

    • Name:
      Janssen Biotech, Inc.
    • Address:
      800/850 Ridgeview Drive, Horsham, PA 19044 US

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Deadlines

    TypeDeadline until

    Type: Frestur til að fara yfir drög að vottorði

    Deadline until: 16.09.2024

    Upload documents